Evaluation of a Lung Ultrasound Score in Hospitalized Adult Patients with COVID-19 in Barcelona, Spain
Authors:
- Maria S. LightowlerMaria S. Lightowler
- Julia Verena SanderJSJulia Verena Sander
- Gonzalo García de Casasola SánchezGSGonzalo García de Casasola Sánchez
- Maria Mateos GonzálezMGMaria Mateos González
- Robert Güerri-FernándezRGRobert Güerri-Fernández
- Maria Dolores Lorenzo NavarroMNMaria Dolores Lorenzo Navarro
- Fabienne NackersFNFabienne Nackers
- Erin StrattaESErin Stratta
- Candelaria LanusseCLCandelaria Lanusse
- Helena HuergaHHHelena Huerga
Open Access
- 2 June 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (11) , 3282
Abstract
Background/Objectives: During the COVID-19 pandemic and the burden on hospital resources, the rapid categorization of high-risk COVID-19 patients became essential, and lung ultrasound (LUS) emerged as an alternative to chest computed tomography, offering speed, non-ionizing, repeatable, and bedside assessments. Various LUS score systems have been used, yet there is no consensus on an optimal severity cut-off. We assessed the performance of a 12-zone LUS score to identify adult COVID-19 patients with severe lung involvement using oxygen saturation (SpO2)/fractional inspired oxygen (FiO2) ratio as a reference standard to define the best cut-off for predicting adverse outcomes. Methods: We conducted a single-centre prospective study (August 2020–April 2021) at Hospital del Mar, Barcelona, Spain. Upon admission to the general ward or intensive care unit (ICU), clinicians performed LUS in adult patients with confirmed COVID-19 pneumonia. Severe lung involvement was defined as a SpO2/FiO2 ratio 2/FiO2 ratio <315 (area under the ROC curve: 0.71; 95%CI 0.64–0.77). After adjustment for COVID-19 risk factors, an admission LUS score ≥17 was associated with an increased risk of in-hospital death (OR 5.31; 95%CI: 1.38–20.4), ICU admission (OR 3.50; 95%CI: 1.37–8.94) and need for IMV (OR 3.31; 95%CI: 1.19–9.13). Conclusions: Although the admission LUS score had limited performance in identifying severe lung involvement, a cut-off ≥17 score was associated with an increased risk of adverse outcomes. and could play a role in the rapid categorization of COVID-19 pneumonia patients, anticipating the need for advanced care.Keywords
Funding Information
- Médecins Sans Frontières—Operational Centre Barcelona
This publication has 45 references indexed in Scilit:
- Can Thoracic Ultrasound on Admission Predict the Outcome of Critically Ill Patients with SARS-CoV-2? A French Multi-Centric Ancillary Retrospective StudyAdvances in Therapy, 2021
- Lung Ultrasound for Identification of Patients Requiring Invasive Mechanical Ventilation in COVID‐19Journal of Ultrasound in Medicine, 2021
- Lung ultrasound predicts clinical course and outcomes in COVID-19 patientsIntensive Care Medicine, 2020
- Comparative study of lung ultrasound and chest computed tomography scan in the assessment of severity of confirmed COVID-19 pneumoniaIntensive Care Medicine, 2020
- A proposed lung ultrasound and phenotypic algorithm for the care of COVID-19 patients with acute respiratory failureCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2020
- Critical Illness in Patients With COVID-19JAMA, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID‐19Journal of Ultrasound in Medicine, 2020
- Diagnostic yield and safety of CT scans in ICUIntensive Care Medicine, 2014
- International evidence-based recommendations for point-of-care lung ultrasoundIntensive Care Medicine, 2012